Paper Details

  1. Home
  2. Paper Details

Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial.

Author: AmblerGareth, EjibeAmaka, GoebelAndreas, KellyJoanna, McCabeCandida, MilliganHolly, MurphyCaroline, PadfieldNick, SandersMark, SerpellMick, ShenkerNicholas, ShoukreyKarim

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Chronic complex regional pain syndrome (CRPS) is often difficult to treat with standard pain medications or other therapies. New treatment options are needed. Early research suggests that low-dose immunoglobulin treatment might significantly reduce pain in people with long-standing CRPS.
Paper Details　
Original Abstract of the Article :
Longstanding complex regional pain syndrome (CRPS) is refractory to treatment with established analgesic drugs in most cases, and for many patients, alternative pain treatment approaches, such as with neuromodulation devices or rehabilitation methods, also do not work. The development of novel, effe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226877/

データ提供：米国国立医学図書館（NLM）

A Novel Oasis: Low-Dose Immunoglobulin Treatment for Complex Regional Pain Syndrome

In the desert of pain, complex regional pain syndrome (CRPS) is like a scorching sandstorm. Many traditional treatments, like analgesics and neuromodulation, often fail to provide relief. This research focuses on exploring a novel oasis of treatment, using low-dose intravenous immunoglobulin (IVIG) for CRPS. The authors are conducting a randomized controlled trial to assess the effectiveness of this treatment approach, which holds the potential to alleviate the suffering of patients who have been struggling for years.

Seeking Relief from the Sandstorm of Pain

This study is like a beacon of hope in the desert of CRPS research. Preliminary data suggest that low-dose IVIG could significantly reduce pain from this debilitating condition. The researchers are carefully evaluating this promising treatment option in a randomized controlled trial, hoping to bring relief to those who have been caught in the sandstorm of chronic pain.

A Potential Solution for CRPS Sufferers

This research is like a wellspring of hope for individuals battling CRPS. If the trial proves successful, low-dose IVIG could offer a new avenue for pain relief, potentially transforming the lives of those affected by this debilitating condition. It's a reminder that even in the most barren deserts of pain, there is always hope for a solution.

Dr. Camel's Conclusion

This research is a beacon of hope in the desert of complex regional pain syndrome. The authors are exploring the potential of low-dose intravenous immunoglobulin as a novel treatment, offering a potential oasis of relief for those who have been struggling with this debilitating condition. This research is a testament to the tireless pursuit of new and effective treatment options for those who suffer from chronic pain.
Date :
  1. Date Completed 2015-07-09
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

25344328

DOI: Digital Object Identifier

PMC4226877

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.